Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rang in Aktien #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aktienkurs
$4.84
Marktkapitalisierung
$633.18M
Veränderung (1 Tag)
3.20%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Exscientia plc (EXAI)
Dividendenrendite (TTM) von Exscientia plc (Aktienkürzel: EXAI) zum 2022-12-31: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Exscientia plc (EXAI) von 2019 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.46%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.00%
AU